Skip to content
HowShorted

Sonnet BioTherapeutics Holdings, Inc. short interest in 2019

In 2019, Sonnet BioTherapeutics Holdings, Inc.'s disclosed short interest ran from 0.91% of shares outstanding on 15 Oct 2019 to 0.36% on 31 Dec 2019, a change of -0.55 percentage points. The year's high was 0.91% on 15 Oct 2019 and its low 0.36% on 31 Dec 2019, averaging 0.55% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.14 days on 31 Dec 2019. Full history: Sonnet BioTherapeutics Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Sonnet BioTherapeutics Holdings, Inc. in 2019

2019 in figures

Start of year
0.91% (15 Oct 2019)
End of year
0.36% (31 Dec 2019)
Change
-0.55 pp
High
0.91% (15 Oct 2019)
Low
0.36% (31 Dec 2019)
Average
0.55%
Highest days to cover
2.14 (31 Dec 2019)
SEC filings marked
8

Every report in 2019

Sonnet BioTherapeutics Holdings, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Oct 20190.91%1.0010-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K)
31 Oct 20190.76%1.00
15 Nov 20190.53%1.6010-Q filed, results (8-K)
29 Nov 20190.39%1.34
13 Dec 20190.37%1.12
31 Dec 20190.36%2.14

See also: Sonnet BioTherapeutics Holdings, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.